Skip to main content

Judge Rogers’ Efforts Pay-off: Parties of The Three Abilify Bellwether cases Agree to Settle

Judge Rogers’ Efforts Pay-off: Parties of The Three Abilify Bellwether cases Agree to Settle

Judge Rogers’ Efforts Pay-off: Parties of The Three Abilify  Bellwether cases Agree to Settle

Introduction

Judge Casey Rogers’ mediation efforts finally paid off as the parties involved in the first three Abilify-gambling bellwether cases agreed to settle the dispute before the scheduled June trials. The formal news was announced by the release of a court order issued by Judge Rogers on April 28 informing that the parties have agreed to settle, though the terms have not been disclosed. The order also states that ‘’the defendants Bristol-Myers Squibb and Otsuka Pharmaceuticals must pay the settlement proceeds to Plaintiffs and, in turn, Plaintiffs must execute full releases, at which time the trial dates will be removed from the Court’s docket.’’

The second round of early bellwether trials is expected to be scheduled soon by Judge Rodgers.

Over 800 Abilify lawsuits were centralized in October 2016 as a part of MDL No. 2734 (In Re: Abilify Compulsive Behavior Products Liability Litigation) in the U.S. District Court for the Northern District of Florida alleging that the defendants failed to warn the consumers and the medical community about the gambling risks associated with Abilify.

Superior Court Judge James De Luca is presiding over the cases filed in the parallel state court litigation established in New Jersey for which trials are expected to begin by the end of this year.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

Purdue, Sacklers Agree to New $7.4B Opioid Settlement

Categories: Opioids

All 50 U.S. states, along with the District of Columbia and U.S. territories, have agreed to a $7.4 billion settlement with Purdue Pharma, the manufacturer of OxyContin.

This deal addresses allegations that the company’s aggressive and…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!